Promedior
 

About Promedior

Leadership in Fibrosis

Scientific Background
Promedior's New Therapeutic Paradigm
 
UNIQUE BENEFITS OF PTX-2
R&D PLATFORM
PRECLINICAL EFFICACY MODELS
Potential of Pentraxin Therapeutics
Publications
Select Links

Pipeline

News & Events

Careers

Contact Us

Home

LEADERSHIP IN FIBROSIS: Select Links

Lung

Kidney

Eye

Skin

Heart

Liver

Other

[ back to top ]

 

Fibrosis is the common pathway in virtually all forms of chronic organ failure, including kidney, liver, lung and heart failure. Fibrotic organ failure affects more than 20 million people in the US alone.

 
   
 

design by Digizyme